SRT Therapeutics, Inc. has raised $47.4M in total funding. The most recent round was Series B.
SRT Therapeutics, Inc. is headquartered in San Diego, CA.
SRT Therapeutics was founded in 2024 by former leaders of Prometheus Biosciences, including President & CEO Lauren Otsuki, and launched with roughly $47M in funding.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.